Corrigendum: Involvement of up-regulation of miR-210 in a rat epilepsy model (Neuropsychiatr Dis Treat., (2016) 12, (1731–1737), 10.2147/NDT.S108190);Involvement of upregulation of miR-210 in a rat epilepsy model

Neuropsychiatric Disease and Treatment

Volumn 12, Issue , 2016, Pages 1731-1737

  Chen, Licheng ^a   Zheng, Hao ^a   Zhang, Shimeng ^a  

^a LINYI PEOPLE'S HOSPITAL   (China)

Author keywords

Epilepsy; Glutamate decarboxylase; MiR 210; aminobutyric acid; aminobutyric acid transaminase

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; GABA TRANSPORTER 1; GLUTAMATE DECARBOXYLASE; LITHIUM CHLORIDE; MESSENGER RNA; MICRORNA 210; PILOCARPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; EPILEPSY; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; MALE; MORPHOLOGY; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; TUNEL ASSAY; UPREGULATION; WESTERN BLOTTING;

EID: 84978477260     PISSN: None     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S146174     Document Type: Erratum

References (30)

1. Behr C, Goltzene MA, Kosmalski G, Hirsch E, Ryvlin P. Epidemiology of epilepsy. Rev Neurol (Paris). 2016;172(1): 27-36.
2. Nevalainen O, Simola M, Ansakorpi H, et al. Epilepsy, excess deaths and years of life lost from external causes. Eur J Epidemiol. Epub 2015 Oct 31.
3. Lhatoo S, Noebels J, Whittemore V, Research NCfS. Sudden unexpected death in epilepsy: Identifying risk and preventing mortality. Epilepsia. 2015;56(11): 1700-1706.
4. Covanis A, Guekht A, Li S, Secco M, Shakir R, Perucca E. From global campaign to global commitment: The World Health Assembly’s Resolution on epilepsy. Epilepsia. 2015;56(11): 1651-1657.
5. Jin Y, Zhao C, Chen L, et al. Identification of novel gene and pathway targets for human epilepsy treatment. Biol Res. 2016;49(1): 3.
6. Li J, Lin H, Niu F, et al. Combined effect between two functional polymorphisms of SLC6A12 gene is associated with temporal lobe epilepsy. J Genet. 2015;94(4): 637-642.
7. Baronas VA, Yang R, Vilin YY, Kurata HT. Determinants of frequency-dependent regulation of Kv1.2-containing potassium channels. Channels (Austin). 2015;10(2): 158-166.
8. Wahab A, Heinemann U, Albus K. Effects of gamma-aminobutyric acid (GABA) agonists and a GABA uptake inhibitor on pharmacoresistant seizure like events in organotypic hippocampal slice cultures. Epilepsy Res. 2009;86(2-3): 113-123.
9. Treiman DM. GABAergic mechanisms in epilepsy. Epilepsia. 2001;42(Suppl 3): 8-12.
10. Mathews GC. The dual roles of GABA in seizures and epilepsy generate more excitement. Epilepsy Curr. 2007;7(1): 28-30.
11. Jin XT, Galvan A, Wichmann T, Smith Y. Localization and function of GABA transporters GAT-1 and GAT-3 in the basal ganglia. Front Syst Neurosci. 2011;5: 63.
12. Gautam V, Singh A, Singh S, Sarkar AK. An efficient LCM-based method for tissue specific expression analysis of genes and miRNAs. Sci Rep. 2016;6: 21577.
13. Hu K, Xie YY, Zhang C, et al. MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus. BMC Neurosci. 2012;13: 115.
14. Xin G, Shi W, Xu LX, Su Y, Yan LJ, Li KS. Serum BAFF is elevated in patients with IgA nephropathy and associated with clinical and histopathological features. J Nephrol. 2013;26(4): 683-690.
15. Zhu G, Li J, He L, Wang X, Hong X. MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway. Br J Pharmacol. 2015;172(9): 2354-2368.
16. Grone BP, Baraban SC. Animal models in epilepsy research: legacies and new directions. Nat Neurosci. 2015;18(3): 339-343.
17. Peng WF, Ding J, Li X, Fan F, Zhang QQ, Wang X. N-methyl-d-aspartate receptor NR2B subunit involved in depression-like behaviours in lithium chloride-pilocarpine chronic rat epilepsy model. Epilepsy Res. 2016;119: 77-85.
18. Long L, Xiao B, Feng L, et al. Selective loss and axonal sprouting of GABAergic interneurons in the sclerotic hippocampus induced by LiCl-pilocarpine. Int J Neurosci. 2011;121(2): 69-85.
19. Morimoto K, Fahnestock M, Racine RJ. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol. 2004;73(1): 1-60.
20. Gurha P. MicroRNAs in cardiovascular disease. Curr Opin Cardiol. 2016;31(3): 249-254.
21. Cherradi N. microRNAs as potential biomarkers in adrenocortical cancer: Progress and challenges. Front Endocrinol (Lausanne). 2015;6: 195.
22. Wang C, Ji B, Cheng B, Chen J, Bai B. Neuroprotection of microRNA in neurological disorders (Review). Biomed Rep. 2014;2(5): 611-619.
23. Bourassa MW, Ratan RR. The interplay between microRNAs and histone deacetylases in neurological diseases. Neurochem Int. 2014;77: 33-39.
24. Wang Y, Ni H, Zhang W, Wang X, Zhang H. Downregulation of miR-210 protected bupivacaine-induced neurotoxicity in dorsal root ganglion. Exp Brain Res. 2016;234(4): 1057-1065.
25. Tan W, Lim SG, Tan TM. Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1. World J Gastroenterol. 2015;21(46): 13030-13041.
26. Pinton P, Giorgi C, Siviero R, Zecchini E, Rizzuto R. Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis. Oncogene. 2008;27(50): 6407-6418.
27. Jiang Y, Li L, Tan X, Liu B, Zhang Y, Li C. miR-210 mediates vagus nerve stimulation-induced antioxidant stress and anti-apoptosis reactions following cerebral ischemia/reperfusion injury in rats. J Neurochem. 2015;134(1): 173-181.
28. Henshall DC. MicroRNAs in the pathophysiology and treatment of status epilepticus. Front Mol Neurosci. 2013;6: 37.
29. Salazar P, Tapia R. Epilepsy and hippocampal neurodegeneration induced by glutamate decarboxylase inhibitors in awake rats. Epilepsy Res. 2015;116: 27-33.
30. Hulsmans M, De Keyzer D, Holvoet P. MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis. FASEB J. 2011;25(8): 2515-2527.